- Tytuł:
- Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
- Autorzy:
- Źródło:
- The Lancet; December-January 2014, Vol. 384 Issue: 9961 p2213-2227, 15p
Periodyk